[18F]-NaF PET/CT imaging in cardiac amyloidosis.

@article{Gucht201618FNaFPI,
  title={[18F]-NaF PET/CT imaging in cardiac amyloidosis.},
  author={Axel Van Der Gucht and Arnault Galat and Jean Rosso and A. Guellich and Jer{\^o}me Garot and Diane Bodez and Violaine Plant{\'e}-Bordeneuve and Luc Hittinger and Jean-Luc Dubois-Rand{\'e} and Eva Evangelista and Myriam Sasanelli and Julia Chalaye and Michel Meignan and Emmanuel Itti and Thibaud Damy},
  journal={Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology},
  year={2016},
  volume={23 4},
  pages={
          846-9
        }
}
Cardiac amyloidosis (CA) is recognized as a common cause of restrictive cardiomyopathy and heart failure due to the deposition of insoluble proteins in the myocardial interstitium. We emphasize the role of [18F]-sodium fluoride (NaF) PET/CT as a potential noninvasive tool to identify and differentiate the transthyretin-related cardiac amyloidosis from the light-chain cardiac amyloidosis. We report cases of a 73-year-old man and a 75-year-old woman followed in our center for congestive heart… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 5 times over the past 90 days. VIEW TWEETS
7 Citations
6 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-6 of 6 references

with ( 99 m ) technetium - hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin - derived systemic amyloidosis

  • Glaudemans AWJM, van Rheenen RWJ, MP vandenBerg, W Noordzij, M Koole, H Blokzijl
  • Bone scintigraphy
  • 2014

Similar Papers

Loading similar papers…